Steady drip vs. shots: which helps heart surgery patients wake up faster?
NCT ID NCT04226495
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether giving the pain medicine sufentanil as a continuous drip during heart surgery helps patients wake up and leave the ICU sooner compared to giving it as single shots. 65 adults having planned heart surgery took part. The goal was to see if the drip method could reduce time on the breathing tube by at least 60 minutes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Sufentanil
- What this could lead to
- If the infusion method works better, it could help patients wake up faster after heart surgery and shorten their time in the ICU.
- What could go wrong
- This is a small, single-center study with only 65 people, so results may not apply to everyone. The difference between the two methods might be small or not meaningful.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANESTHESIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Nebraska Medical Center
Omaha, Nebraska, 68198, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Software-Guided heart procedures: a new standard for coronary care?
- Can a smart pump prevent dangerous drops in blood pressure during C-Sections?
- Can a ketamine boost during surgery slash opioid needs?
- Heart patients may stay active longer with coach calls and group support
- Sitting less could be a lifeline for frail hearts – a new trial tests a simple program
- Can balloon timing make or break heart artery success?